Bank of America’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $575 | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $19K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $0 | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $79K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $11K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $14K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $4K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $37K | Sell |
|
|||||
|
2017
Q2 | $86K | Buy |
|
|||||
|
2017
Q1 | $53K | Hold |
|
|||||
|
2016
Q4 | $44K | Sell |
|
|||||
|
2016
Q3 | $82K | Buy |
|
|||||
|
2016
Q2 | $42K | Sell |
|
|||||
|
2016
Q1 | $87K | Sell |
|
|||||
|
2015
Q4 | $206K | Sell |
|
|||||
|
2015
Q3 | $358K | Buy |
|
|||||
|
2015
Q2 | $215K | Sell |
|
|||||
|
2015
Q1 | $240K | Buy |
|
|||||
|
2014
Q4 | $144K | Buy |
|
|||||
|
2014
Q3 | $115K | Hold |
|
|||||
|
2014
Q2 | $103K | Buy |
|
|||||
|
2014
Q1 | $76K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $23K | Buy |
|